AI
RGEN icon

Analytic Investors’s Repligen RGEN Stock Holding History

Analytic Investors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.18M Hold
39,080
– – 0.01% 348
2016
Q2 		$1.07M Sell
39,080
-22,541
-37% -$576K 0.01% 370
2016
Q1 		$1.65M Buy
61,621
+5,641
+10% +$138K 0.02% 332
2015
Q4 		$1.58M Buy
55,980
+21,156
+61% +$610K 0.02% 325
2015
Q3 		$970K Buy
+34,824
New +$1.26M 0.01% 376
2014
Q3 		– Sell
-82,844
Closed -$1.89M – 652
2014
Q2 		$1.89M Sell
82,844
-35,226
-30% -$627K 0.03% 255
2014
Q1 		$1.52M Buy
+118,070
New +$1.69M 0.02% 312

Other funds holding RGEN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Analytic Investors's RGEN Position: Q3 2016 in Review

Analytic Investors held its Repligen (RGEN) position steady in Q3 2016 at 39,080 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #348.

Analytic Investors first reported a position in RGEN in Q1 2014 and has held it in 7 quarters since. The position peaked at $1.89M in Q2 2014. 181 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.

  • Analytic Investors held 39,080 shares of Repligen worth $1.18M as of Q3 2016.
  • Analytic Investors left its Repligen share count unchanged in Q3 2016.
  • Repligen made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #348 holding.
  • Analytic Investors first reported a position in Repligen in Q1 2014 and has held it in 7 quarters since.
  • Analytic Investors's Repligen position peaked at $1.89M in Q2 2014.
  • 181 funds tracked by Wall St. Rank held Repligen as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.